TRIER PHARM ApS: Financial statements 2021
CVR: 31611083
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 31,869 and a net result of DKK 9,192 compared with DKK -56,020 the year before. Equity in the 2021 report amounted to DKK -466,531.
- Gross Profit
- DKK 31,869
- Profit/Loss
- DKK 9,192
- Equity
- DKK -466,531
- Total Assets
- DKK 508,208
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 32 t. | 9 t. | -467 t. | - |
| 2020 | - | -35 t. | -56 t. | -476 t. | - |
| 2019 | 528 t. | -24 t. | -40 t. | -420 t. | - |
| 2018 | 470 t. | -3 t. | -21 t. | -380 t. | - |
| 2017 | 481 t. | 20 t. | 2 t. | -359 t. | - |
Official annual report
Find more companies like TRIER PHARM ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
TRIER PHARM ApS has published its annual report for 2020. Gross profit came to DKK -35,048, and the net result was DKK -56,020.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.